Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Heartport cost reductions please Wall Street

This article was originally published in Clinica

Executive Summary

Heartport, a minimally-invasive cardiac surgery company called 1998 a "pivotal year", as it published its year-end figures, showing that sales had dropped to $19 million from $23 million. During 1998 the company was forced to restructure and cut staff by a third, as surgeon acceptance of the company's Port-Access procedure was questioned (see Clinica No 807, p 13). Nonetheless, one prominent New York analyst is pleased with how the Redwood City, California-based company has "reined in costs" and with the launch of its new product, the EndoDirect system. While the last quarter's figures showed sales of just under $5 million, compared with the $8 million of the previous year, Glenn Reicin of Morgan Stanley Dean Witter said that the figure was some $500,000 better than the analysts' estimate. Losses from operations for the quarter were $4 million and $12 million for the year.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT077531

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel